Neurochemical investigation of an endogenous model of the "hyperkinetic syndrome" in a hybrid dog.

[1]  B. Shaywitz,et al.  Paradoxical response to amphetamine in developing rats treated with 6-hydroxydopamine , 1976, Nature.

[2]  P. Morselli,et al.  Urinary excretion of 3-methoxy-4-hydroxyphenylglycol sulfate in rats after intraventricular injection of 6-OHDA. , 1974, Brain research.

[3]  A. Guidotti,et al.  Simultaneous isolation of adenosine 3',5'-cyclic monophosphate (cAMP) and guanosine 3',5'-cyclic monophosphate (cGMP) in small tissue samples. , 1974, Analytical biochemistry.

[4]  M. W. Sauerhoff,et al.  Hyperactivity and Brain Catecholamines in Lead-Exposed Developing Rats , 1973, Science.

[5]  P. Wender.  SOME SPECULATIONS CONCERNING A POSSIBLE BIOCHEMICAL BASIS OF MINIMAL BRAIN DYSFUNCTION , 1973, Life sciences.

[6]  D. Cantwell,et al.  EEG ASPECTS IN THE DIAGNOSIS AND TREATMENT OF MINIMAL BRAIN DYSFUNCTION * , 1973, Annals of the New York Academy of Sciences.

[7]  L. Arnold,et al.  Levoamphetamine and dextroamphetamine: differential effect on aggression and hyperkinesis in children and dogs. , 1973, The American journal of psychiatry.

[8]  J. Meek,et al.  Fluorometric estimation of 4‐hydroxy‐3‐methoxyphenylethyleneglycol sulphate in brain , 1972, British journal of pharmacology.

[9]  S. Snyder,et al.  Differential effects of D- and L-amphetamine on behavior and on catecholamine disposition in dopamine and norepinephrine containing neurons of rat brain. , 1971, Brain research.

[10]  J. Korf,et al.  Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. , 1971, Biochemical pharmacology.

[11]  C. Chang.  A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES. , 1964, International journal of neuropharmacology.

[12]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[13]  B. Shaywitz,et al.  CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. A preliminary report. , 1977, The Journal of pediatrics.

[14]  P. Wender.  The minimal brain dysfunction syndrome. , 1975, Annual Review of Medicine.

[15]  E. Silbergeld,et al.  Lead-induced behavioral dysfunction: an animal model of hyperactivity. , 1974, Experimental neurology.